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D. Broe,* P.F. Ridgway, S. Tierney and T.M. FeeleyDepartment of Vascular Surgery, Adelaide, Meath and National Children’s Hospital,
Tallaght, Dublin 24, IrelandLong-term survivors following renal transplantation may get abdominal aortic aneurysms (AAA) requiring operative
intervention. Conventional open AAA repair necessitates a period of warm ischaemia to a renal transplant, and
renoprotective manoeuvres are often inadequate. The introduction of endovascular strategies may represent a minimised risk
method to repair the aneurysm. We report endovascular stenting of asymptomatic AAAs in two male patients with
functioning renal transplants. Both patients had significant cardiovascular co-morbidity and chronic allograft nephropathy.
Preoperative management included intravenous hydration and oral N-acetylcysteine. Both patients remained on
immunosuppressant medication throughout. Following successful repair, these patients recovered without complication.
Postoperative biochemical renal function returned to baseline in both cases. We conclude that endovascular repair of an AAA
is a good surgical option for those with functioning renal allografts.Keywords: Endovascular repair; Allograft nephropathy; Abdominal aortic aneurysm.Introduction
Long-term survivors following renal transplantation
herald a potential increase in abdominal aortic
aneurysms (AAA) requiring operative intervention.
Despite this little is published regarding management
of this complex problem. Conventional open AAA
repair necessitates a significant period of warm
ischaemia to a renal transplant, and renoprotective
manoeuvres are often inadequate.
We report endovascular stenting of asymptomatic
AAAs in two male patients with functioning renal
transplants. Both patients, aged greater than 60 years,
had significant co-morbidity as well as chronic
allograft nephropathy. The aneurysm had been
discovered incidentally on radiological imaging and
had been followed until they reached over 5.5 cm in
diameter. Given their level of renal impairment,
endovascular techniques were deemed more suitable
than traditional open aneurysm repair. Preoperativeing author. D. Broe, MB, BCh, IMRCS, Department of
rgery, Adelaide, Meath and National Children’s
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N-acetylcysteine. Following successful repair, these
patients recovered without complication. Postopera-
tive renal function returned to baseline in both cases.
We conclude that endovascular repair of an AAA is a
definite surgical option for those with functioning
renal allografts.Case ReportsCase 1
A 67-year-old man had developed end stage renal
failure secondary to IgA nephropathy. He underwent
continuous ambulatory peritoneal dialysis (CAPD) for
a year prior to successful renal transplantation 6 years
ago. This patient had an abdominal computed
tomographic (CT) scan for investigation of a possible
lymphocoele in 2002. However, the scan revealed an
incidental infra-renal AAA measuring 4.4 cm in
diameter. Subsequent follow-up ultrasonography
revealed that the aneurysm had increased to 6.5 cmEJVES Extra 11, 36–39 (2006)
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ischaemic heart disease, hypertension, mitral valve
disease and transient ischaemic attacks. He also had an
element of chronic allograft nephropathy with a
baseline serum creatinine ranging between 180 and
190 mmol/l. Magnetic resonance angiography (MRA)
confirmed an infra-renal AAA commencing 1.8 cm
from the renal arteries with no associated aneurysmal
dilatation of the iliac vessels.
Preoperatively, he was prehydrated with intrave-
nous fluids and also given a course of N-acetylcysteine
in order to minimise the nephrotoxic effects of the
contrast. Both common femoral arteries were exposed
and controlled in standard fashion under general
anaesthesia. The right femoral artery was cannulated
and transluminal angiography was performed to
determine the position of the neck of the aneurysmal
sac. This allowed appropriate positioning of a Cookw
(Cook Inc., IN, USA) bifurcated endograft. The
proximal endograft was positioned just below the
level of the renal arteries before deployment. A right
iliac endograft extension was placed distally above the
right common iliac bifurcation. A left iliac endograft
extension was then also deployed. Final angiography
films demonstrated complete exclusion of the
aneurysm.
The procedure was tolerated very well without
complication. The patient was discharged on the 8th
postoperative day. Baseline renal function had
returned by the 3rd postoperative day and has
remained unaltered during regular follow-up.
Follow-up CT scanning revealed no evidence of
endoleak with complete exclusion of the aneurysmal
sac. His renal transplant demonstrated appropriate
uptake of galladinium dye.Fig. 1.This 3 month follow-up abdominal CT slice shows
the proximal aspect of the endograft with exclusion of
blood flow into the surrounding aneurysm sac (Fig. 1).Case 2
This 69-year-old man developed end stage renal
disease secondary to autosomal dominant polycystic
kidney disease. He received a conventional renal
allograft located in the right iliac fossa 8 years prior
to presentation. He had an incidental finding of an
AAA measuring 4.2 cm in diameter found on abdomi-
nal ultrasonography 5 years following renal trans-
plantation. He had subsequent 6 monthly ultrasound
scans until his AAA had increased in size to 5.8 cm in
diameter. An abdominal CT scanning revealed an
infra-renal AAA with no aneurysmal dilatation of the
iliac vessels.
This patient had significant cardiovascular co-
morbidity including hypertension, ischaemic heart
disease, hypercholesterolaemia and carotid artery
stenosis for which had previously undergone a right
carotid endarterectomy. This gentleman also had
chronic allograft nephropathy with a baseline serum
creatinine between 165 and 175 mmol/l.
Following extensive preoperative evaluation, he
also received prophylactic intravenous fluid hydration
and oral N-acetylcysteine. The endovascular repair
was performed under general anaesthesia. A bifur-
cated Cookw endograft was deployed initially. The
graft was advanced through an arteriotomy in the
right femoral artery, through the right iliac artery and
placed inferiorly to the native renal arteries. A right
and left endograft extension were placed in the right
and left common iliac arteries, respectively. Com-
pletion angiography demonstrated exclusion of the
aneurysm sac. This patient recovered without compli-
cation and was discharged by the 9th postoperative
day. Follow-up CT scanning has demonstrated com-
plete exclusion of flow into the aneurismal sac.Discussion
As patients with functioning renal allografts have a
high incidence of concurrent cardiovascular disease,
particularly hypertension, they may be more suscep-
tible to the development of aneurysmal disease.
Conventional open AAA repair necessitates a
significant period of warm ischaemia to a transplanted
kidney. There is limited evidence to support open
AAA repair in this population group. Skelly and
colleagues reported two cases who underwentEJVES Extra Vol 11, March 2006
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recovered uneventfully without a deterioration in
renal function. In each case, warm renal ischaemia
time was limited to less than 35 min. They concluded
that standard surgery without adjunctive shunts or
bypasses is a viable treatment.
A number of authors have reported on successful
AAA repair using intraoperative renoprotective tech-
niques. Temporary vascular shunting appears to be the
most common method used. Kashyap et al. reported
on two separate modalities that were successfully used
to protect the functioning renal transplant.2 One
technique involved an aortofemoral shunt using the
perirenal aorta for proximal cannulation and the other
technique utilized an indwelling shunt through the
prosthetic graft. Other authors have used temporary
axillo-femoral bypass grafting with good response
following surgery.3 As well as shunting, cold renal
perfusion and hypothermia have been used to protect
the renal transplant with limited success.4–6
Both our two reported cases had chronic allograft
nephropathy. Norwood reported on conventional
AAA repair in patients with chronic renal disease.7
They concluded that AAA repair in patients with renal
impairment was associated with increased postopera-
tive morbidity and mortality, and had a longer ICU
and overall hospital stay. Patients who were not
previously on dialysis therapy also had a higher risk
of subsequent long-term dialysis.
We felt that open AAA repair represented a great
risk to the functioning renal transplant. Endovascular
strategies have recently been introduced and although
there is limited evidence in the literature it was
reasoned that this technique represented a minimised
risk method to restore normal luminal diameters.
Ailawadi et al. reported on two patients with
functioning renal transplants who successfully under-
went endovascular AAA repair.8 Both patients toler-
ated the procedure without complication and had an
uneventful postoperative course. Renal function was
measured by serum creatinine and this remained
unchanged in the immediate and longer-term post-
operative period. There have been three other single
case reports showing promising results in patients
undergoing endovascular repair in the presence of a
coexisting renal allograft.9–11 In each case, perfusion to
the allograft was maintained throughout the pro-
cedure. This was only discontinued for short periods
when the graft was being expanded with a balloon.
Our findings support their assertion that endovascular
treatment did not appear to place the transplanted
kidney at greater ischaemic risk. This may be due to
warm renal ischaemia time during this operativeEJVES Extra Vol 11, March 2006technique being substantially reduced compared to
traditional open repair.
We feel that preoperative renoprotective techniques
must be employed in these patients. In our cases, a
multidisciplinary approach minimised the deleterious
effect of contrast nephrotoxicity and optimised
management of immunosupression in the periopera-
tive period. Both patients were on a combination of
immunosupressants including azothioprine, cyclos-
porine and prednisolone. Each patient received a 48 h
boost of intravenous hydrocortisone preoperatively
which was weaned in the postoperative period with
resumption of oral intake. Despite this level of
immunosupression, no wound complications were
encountered. Prior to contrast use, each patient was
prehydrated intravenously and also given N-acetyl-
cysteine (600 mg twice daily) orally as standard.
During initial and follow-up CT scanning, 80 ml of
iopamidol contrast dye was used. The use of contrast
was minimised during the operation. This amounted
to 160–190 ml of iopamidol in each case. Contrast
induced nephropathy was not encountered.
Radiocontrast is reported to be the third most
common of new onset renal failure in hospital
patients.12 Prevention trials have focused on the use
of blood volume expansion, low osmolality versus high
osmolality contrast, dopamine, diuretic treatment,
and, most recently, N-acetylcysteine. Convincing
evidence of benefit in patients with impaired renal
function has been observed with the use of 0.45%
saline and low osmolality contrast medium.13
Although low-osmolar contrast agents such as iopa-
midol are commonly used, it has been suggested that
the use of iso-osmolar contrast agents confers greater
renoprotection in patients with underlying renal
impairment. A recent study also suggests that the
dose of iso-osmolar contrast was not necessarily
associated with the development of a higher incidence
of contrast induced nephropathy.14 Others have
reported the benefit from the oral administration of
the antioxidant N-acetylcysteine in patients exposed to
intravenous contrast.15–17Conclusion
We conclude that endovascular grafting is a safe and
efficacious method for repair of AAAs in selected
patients with functioning renal transplants. Deterio-
ration of renal function in patients with chronic
allograft nephropathy who are undergoing surgery
may be minimised with preoperative intravenous
hydration and oral N-acetylcysteine.
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